Last reviewed · How we verify
NCT04187651
PRP Use in Treatment of Fistula Ano
NA trial testing platelet rich plasma in Fistula in Ano in 100 participants. Participants enrolled and being followed up; not accepting new ones.
1 January 2025
Quick facts
| Lead sponsor | Uşak University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 20 November 2019 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- platelet rich plasma — full drug profile →
Conditions studied
- Fistula in Ano — all drugs for Fistula in Ano →
Sponsor
Uşak University
Who can join
18 and older, any sex, with Fistula in Ano. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In treatment of perianal fistula several methods are described. However, since the Hippocrates basics of surgical treatment has not changed very much. the aim of this study is to evaluate the effectiveness of PRP gel in treatment of perianal fistula.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04187651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of platelet rich plasma
Trials testing the same drug.
- NCT06319768 — Efficacy of Intralesional Injection of Pentoxifylline, Platelet-Rich Plasma, and Combined Pentoxifylline With Platelet-R · NA · unknown
- NCT05795660 — The Effect of Platelet Rich Plasma for the Treatment of Osteochondral Lesions of the Talus · Phase 1 · not yet recruiting
- NCT06249503 — Ultrasound Guided Activated and Non Activated Platelet Rich Plasma Injection Versus Hydro Dissection by Steroids. · Phase 4 · completed
- NCT05603468 — Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair · Phase 4 · active not recruiting
- NCT05339542 — Platelet Rich Plasma in Plantar Fasciitis · NA · completed
Other recruiting trials for Fistula in Ano
Currently open trials in the same condition.
- NCT07519850 — The Impact of Perianal Disease on Patient's Sex Life · recruiting
- NCT07035925 — Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas · NA · recruiting
- NCT05666609 — Fistula-in-ano in Infants and Children · NA · recruiting
- NCT05039411 — Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease · Phase 1 · recruiting
Other Uşak University trials
Trials by the same sponsor.
- NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
- NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
- NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
- NCT07296367 — Physiotherapy and Disaster · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04187651 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uşak University
- Last refreshed: 29 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing